These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27512733)

  • 1. Resolution of osteosclerosis after alloHCT in systemic mastocytosis.
    Ustun C; Courville EL
    Blood; 2016 Apr; 127(14):1836. PubMed ID: 27512733
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.
    Jordan JH; Fritsche-Polanz R; Sperr WR; Mitterbauer G; Födinger M; Schernthaner GH; Christian Bankl H; Gebhart W; Chott A; Lechner K; Valent P
    Leuk Res; 2001 Jul; 25(7):627-34. PubMed ID: 11377687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis].
    Sotlar K
    Verh Dtsch Ges Pathol; 2007; 91():169-76. PubMed ID: 18314612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene.
    Yavuz AS; Lipsky PE; Yavuz S; Metcalfe DD; Akin C
    Blood; 2002 Jul; 100(2):661-5. PubMed ID: 12091362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slowly progressive systemic mastocytosis with high mast-cell burden and no evidence of a non-mast-cell hematologic disorder: an example of a smoldering case?
    Akin C; Scott LM; Metcalfe DD
    Leuk Res; 2001 Jul; 25(7):635-8. PubMed ID: 11377688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIT and mastocytosis.
    Lim KH; Pardanani A; Tefferi A
    Acta Haematol; 2008; 119(4):194-8. PubMed ID: 18566536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.
    Sotlar K; Marafioti T; Griesser H; Theil J; Aepinus C; Jaussi R; Stein H; Valent P; Horny HP
    Mol Pathol; 2000 Aug; 53(4):188-93. PubMed ID: 11040941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mastocytosis: advances in diagnosis and treatment.
    Hungness SI; Akin C
    Curr Allergy Asthma Rep; 2007 Jul; 7(4):248-54. PubMed ID: 17547845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.
    Nagata H; Worobec AS; Oh CK; Chowdhury BA; Tannenbaum S; Suzuki Y; Metcalfe DD
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10560-4. PubMed ID: 7479840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation.
    Zappulla JP; Dubreuil P; Desbois S; Létard S; Hamouda NB; Daëron M; Delsol G; Arock M; Liblau RS
    J Exp Med; 2005 Dec; 202(12):1635-41. PubMed ID: 16352739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial occurrence of systemic and cutaneous mastocytosis in an adult multicentre series.
    Tanasi I; Bonifacio M; Pizzolato M; Irene Grifoni F; Sciumè M; Elena C; Benvenuti P; Mannelli F; Parente R; Schena D; Scaffidi L; Bonadonna P; Papayannidis C; Rondoni M; Criscuolo M; Vannucchi AM; Triggiani M; Martinelli G; Krampera M; Zanotti R
    Br J Haematol; 2021 May; 193(4):845-848. PubMed ID: 33754335
    [No Abstract]   [Full Text] [Related]  

  • 12. Mastocytosis: molecular mechanisms and clinical disease heterogeneity.
    Metcalfe DD; Akin C
    Leuk Res; 2001 Jul; 25(7):577-82. PubMed ID: 11377683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit.
    Gerbaulet A; Wickenhauser C; Scholten J; Peschke K; Drube S; Horny HP; Kamradt T; Naumann R; Müller W; Krieg T; Waskow C; Hartmann K; Roers A
    Blood; 2011 Feb; 117(6):2012-21. PubMed ID: 21148330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of KIT Mutations in Anaphylaxis.
    Coulson E; Zhou S; Akin C
    Curr Allergy Asthma Rep; 2019 Apr; 19(6):31. PubMed ID: 31028494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the understanding of mastocytosis: the role of KIT mutations.
    Orfao A; Garcia-Montero AC; Sanchez L; Escribano L;
    Br J Haematol; 2007 Jul; 138(1):12-30. PubMed ID: 17555444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic and molecular genetic abnormalities in systemic mastocytosis.
    Gupta R; Bain BJ; Knight CL
    Acta Haematol; 2002; 107(2):123-8. PubMed ID: 11919394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT.
    Foster R; Byrnes E; Meldrum C; Griffith R; Ross G; Upjohn E; Braue A; Scott R; Varigos G; Ferrao P; Ashman LK
    Br J Dermatol; 2008 Nov; 159(5):1160-9. PubMed ID: 18795925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mastocytosis cells bearing a c-kit activating point mutation are characterized by hypersensitivity to stem cell factor and increased apoptosis.
    Dror Y; Leaker M; Caruana G; Bernstein A; Freedman MH
    Br J Haematol; 2000 Mar; 108(4):729-36. PubMed ID: 10792276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives.
    Arock M; Valent P
    Expert Rev Hematol; 2010 Aug; 3(4):497-516. PubMed ID: 21083038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIT D816V- chronic myelomonocytic leukemia progressing to KIT D816V+ associated to mast cell leukemia responding to allogeneic hematopoietic cell transplantation.
    Prats-Martín C; Jiménez-Guerrero P; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; Pérez O; Montero I; Falantes J; Burillo-Sanz S; Carrillo E; Borrero JJ; Bernal R; Pérez-Simón JA
    Ann Hematol; 2018 Mar; 97(3):533-535. PubMed ID: 29151134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.